J. Goldman & Co’s Johnson & Johnson JNJ Stock Holding History

J. Goldman & Co’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,900	Closed	-$709K	–	809
2026 Q1	$709K	Sell	2,900 -63,081	-96%	-$14.7M	0.02%	463
2025 Q4	$13.7M	Buy	+65,981	New	+$13M	0.36%	77
2023 Q3	–	Sell	-160,694	Closed	-$26.6M	–	420
2023 Q2	$26.6M	Buy	+160,694	New	+$25.9M	0.97%	21
2022 Q4	–	Sell	-51,666	Closed	-$8.44M	–	428
2022 Q3	$8.44M	Buy	+51,666	New	+$8.74M	0.4%	80

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

J. Goldman & Co's JNJ Position: Q2 2026 in Review

J. Goldman & Co sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 2,900 shares — an estimated $709K sold.

J. Goldman & Co first reported a position in JNJ in Q3 2022 and held it in 4 quarters. The position peaked at $26.6M in Q2 2023. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

J. Goldman & Co reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
J. Goldman & Co sold 2,900 Johnson & Johnson shares in Q2 2026, an estimated $709K.
J. Goldman & Co first reported a position in Johnson & Johnson in Q3 2022 and held it in 4 quarters.
J. Goldman & Co's Johnson & Johnson position peaked at $26.6M in Q2 2023.
4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.